VCR - Ventracor Limited

This share is doing pretty well lately. Any idea what is the current support level?

Couple of interesting announcements out yesterday.

No budge in the price yet... keeping an eye on it anyway.

Oh no...dropped below $1.00 and today looks pretty bad...

I gave up on this, sold all. But I do hope this share can at least hold above 95c.

PhoenixXx said:

I gave up on this, sold all. But I do hope this share can at least hold above 95c.

Click to expand...

Can anyone explain the vcr big red candle? Is this insider trading and is there something bad we don't know about? Closed 4pm 0.935, down 0.065. I did hear "there was a "suck down" effect for the recipient whereby the ventricle will collapse temporarily if the pump's revs are too high, or the patient does not have enough blood volume. If the pump isnt getting any blood it apparently just keeps spinning with no cardiac output" Is this true? Does anyone know if Ventracor has commented on this issu, if it is an issue? Does anyone know more? Doesn't seem to have been a reverse speeding ticket and no company announcement to precipitate this dummy spit. I hold but not for longer if there are problems.

Hi all you VCR faithful,

VCR - potential cash flow for this calender year.

If we assume that the trials in the US begin (shortly) and we use the following data from previous announcements or their prospectus - you get the following cashflow from revenues derived in the US : -

1. BTT - total implants 100 over 18 months ----------say 50 this year.

2. DT - total implants 240 0ver 24 months ----------say 100 this year.

Now note that they will have 20 - 25 centers implanting and that the issue regarding patients being discharged home has been sorted....They also mentioned something about faster recruitment for the DT................i don't have a clue as to how they will speed it up.........................

..so before everyone starts complaining that VCR took 1.5 years to complete 10 patients and how the hell are they going to complete 150 on one year.............well you have to just consider that they have been through the hard part (initiating the trials) ....and with 20-25 centers on line that would mean something like 1 person every 1.5 months at each center,,,,,,not overly difficult you would think.

That would then give us $140K x 150 = $21 million

As for Europe they hoped to complete 100 patients over 2 years for the BRACE study so add 50 implants at $100K (i am assuming reinbursments are less for europe and not all are being reimbursed) x 50% = $2.5 Million.

Now add SALES of the device to Europe...............we know they have 6 centers operating in Europe............UK, Norway, two in FRANCE, Germany and can't think of the other at moment (maybe someone can help me out there)................if they sold say 10 to each then we have another 60 at $100K then you could have another $6million. Remember 10 is a guess ....it could be 1 or 100 i don't know.....

That would make it 260 devices over one year and we know for a fact that they can produce 50 per month at moment so 260 is less that their current capacity.

So all in all a total of $29.5 Million Revenue..........................we know they are spending up to $30 million over a year and they would have cash as of start of 2007 of approximatley say $52Million (JUNE 2006) less $20 million (second half of 2006).= $30 million.

So all in all if they play it right they could generate enough revenue to cancel out their expenses for the year.......and retain say $20- 30million in cash for the following year and so on.............. until VCR can stand on its two feet without needing further cash injections..........at worst if they need any further funds down the track it shouldn't be too much and hopefully the price is higher....................

You can now feel free to shoot me down as being OVERLY optimistic but hey the cup is always half full for me...............except when VCR drops 6.5 cents. in one day.

GO VCR


regards
savtin

Its a typical biotech stock but in a much adavanced stage than others. I think they are close to breaking through and shedding the day traders favourite stock. There has been millions of dollars poured into this stock by shareholders so its no wonder it goes up and down like a yoyo. It needs those revenues and a reduction in cashburn v revenue ratio. Once that under control should be no more dilution and iif company becaomes succesful who knows where it might end up? I'm a long term holder and bullish on its technology and prospects

savtin said:

Hi all you VCR faithful, VCR - potential cash flow for this calender year.(etc.) GO VCR regards savtin

Click to expand...

Looks even better if you add in 2.8 mil "SYDNEY, Australia 23 January 2007: Ventracor (ASX: VCR) today announced the award of a $2.8 million Commercial Ready Grant from the Australian Federal Government to fund further development of the VentrAssist™ left ventricular assist device (LVAD)."

Re: VCR - Ventracor Limited Interview tonight

This should be great tonight..........have your seats glued to the set.

Interview with CEO Peter Crosby will air live tonight on Sky News Business from 8:30 pm Sydney time.



You can view on FOXTEL (digital 601, analogue 34), AUSTAR (channel 601) or OPTUS (DIGITAL 601, ANALOGUE 48) or podcast http://www.skynews.com.au/ondemand/

GO VCR

breakout!

I saw that... wth!?

Hopefully it keeps going strong... I jumped in a second before the dive a few weeks ago and am ready to move on

What is with this Almighty FDA anyway...........are they still reviewing the data for the VCR device to determine in their own mind that it works................you would have thought it was a no brainer a mere formality to review the data and come to the conclusion that the European body came to and let the device begin the REAL trials.....it's crazy.............the FDA has had VCR in PRE-TRIALS since Aug 2005 and now we are in March 2007 and yes we are still in feasibilty mode.............ITS %$^$ crazy.................i mean the FDA can keep VCR in holding mode indefinatley....................... if they have an issue with the devise then they should come out and say so or else let them begin...................................

Let us all hope that VCR can atleast pool the data from the US feasibility trial because then we would have already completed 30 from the 140 total.........

on the 14th FEb VCR had completed 90 mI would have thought one month later that 100 patients would be complete and we'll get an announcement on reaching that figure??????

I guess any NEWS from VCR now would be good now.....................ESPECIALLY SOME CASH FROM SALES IN EUROPE....THAT WILL GET THE HEARTBEAT GOING......MAYBE EVEN INTEREST THE WALLETS OF THE BIG FUNDIES ................FINALLY.

Mate, I understand how you're feeling. It's rather frustrating at times especially looking at other stocks/indexes going north. That's typical VCR and bio/pharmaceutical stocks. On the other hand, we should give management some credits for putting everything in place in order to fast track the approval process.

Compared CCE, also excellent but simpler product, well known founder Dr. Fiona Wood sp keeps getting hammered due to poor management, delays, no cash, low sales etc etc.. lots of excuses...

To all VCR supporters, we've come this far and we all know the upside (once its approved and generate sales, it will make COH looks like nothing)

My opinion: Hold, hold, hold and accumulate.

There are some new Announcements for the 13th check them out a new trail approval in the US to possibly fast track production.

Just a reminder, Chief Executive Officer Peter Crosby will present at the 27th annual Cowen and Company Healthcare Conference on 14 March at 9:30am US Eastern Time (01:30am Sydney Thursday 15 March). The conference will be held at The Marriott Copley Place Boston 12 - 15 March 2007.

Further info visit www.ventracor.com For information about Cowen and Company visit: www.cowen.com

This is our chance to win some american investors.

~5% jump today so far.

Quite a large jump in volume. 1.5 mil today so far compared to 250k avg.

Announcement soon?

Hi all,
Hope you are all having a lovely break.

Back to speculation mood....i was wondering the otherday what will it need to break the $1.20 resistance barrier for this stock and I came up with the following possibilities(mind you the list it is not exhaustive and someone may want to add anything I missed): -

1. NO news. Technical action / momentum.
2. Green light to begin the DT trial.
3. TGA approval in Australia.
4. News that Directors buying.
5. TETS product released to market.
6. News of a SALES order from a European Country
7. Institution taking stake (although i feel that in order for this to happen the price would have been driven up over $1.20 when the announcement comes through so I was hesitant on putting this on the list.....and for the institution to buy in will probably rely on news items from items 2. to 6. bove.)
7. News that Implanting centers in Europe expanding at a rapid rate.

8. Any news that indicates that the product is being implanted in the BTT trial at a rapid pace.


My personal opinion is that item 2. and then with item 1. will be enough to get us over the line.

Cheers all

Kind regards Savtin

GO VCR...............the pieces are slowly falling into place.

I'm thinking that technical momentum is what will take us convincingly over $1 in the near term.
I'd be surprised if European sales are not announced soon as the hint in the last investor update was that now with CE mark approval more of these (European implants) will contribute to revenue.

I'm still in with all the beaten and battered long standing shareholders of this puppy... Lets see some action

Who are these institutional "sophisticated" investors that can request a share placement?

Surely more shares on the market just dilutes our shares even further and will push the share price down again, or are these institutional investors likely to generate more interest in the Ventrassist and give us a boost.

Methinks I've held these for too long with no reward, but as always they show so much potential....

Bazmate said:

Who are these institutional "sophisticated" investors that can request a share placement?

Surely more shares on the market just dilutes our shares even further and will push the share price down again, or are these institutional investors likely to generate more interest in the Ventrassist and give us a boost.

Methinks I've held these for too long with no reward, but as always they show so much potential....

Click to expand...

I gave up on these a long time ago. I was in early but fell into the trap of increasing my holding at $2.25 along with a lot of other true believers in the product. They seem to prefer to raise funds at discount prices to institutions which as you say dilutes the share value as the market cap does not increase. They have all their eggs in one basket making them high risk to my way of thinking.